Evolocumab is initiated in Central and Eastern Europe at Much Higher LDL-C Levels than Recommended in Guidelines: Results from the Observational HEYMANS Study

Detalles Bibliográficos
Autores principales: Blaha, V, Margoczy, R, Petrov, I, Postadzhiyan, A, Raslova, K, Rosolova, H, Bridges, I, Dhalwani, NN, Zachlederova, M, Ray, KK
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Radcliffe Cardiology 2023
Materias:
27th Annual Meeting of the ISCP
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10316339/
https://www.ncbi.nlm.nih.gov/pubmed/37405342
http://dx.doi.org/10.15420/ecr.2023.18.PO19
_version_ 1785067688549154816
author Blaha, V
Margoczy, R
Petrov, I
Postadzhiyan, A
Raslova, K
Rosolova, H
Bridges, I
Dhalwani, NN
Zachlederova, M
Ray, KK
author_facet Blaha, V
Margoczy, R
Petrov, I
Postadzhiyan, A
Raslova, K
Rosolova, H
Bridges, I
Dhalwani, NN
Zachlederova, M
Ray, KK
author_sort Blaha, V
collection PubMed
description
format Online
Article
Text
id pubmed-10316339
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Radcliffe Cardiology
record_format MEDLINE/PubMed
spelling pubmed-103163392023-07-04 Evolocumab is initiated in Central and Eastern Europe at Much Higher LDL-C Levels than Recommended in Guidelines: Results from the Observational HEYMANS Study Blaha, V Margoczy, R Petrov, I Postadzhiyan, A Raslova, K Rosolova, H Bridges, I Dhalwani, NN Zachlederova, M Ray, KK Eur Cardiol 27th Annual Meeting of the ISCP Radcliffe Cardiology 2023-04-25 /pmc/articles/PMC10316339/ /pubmed/37405342 http://dx.doi.org/10.15420/ecr.2023.18.PO19 Text en Copyright © 2023, Radcliffe Cardiology https://creativecommons.org/licenses/by-nc/4.0/This work is open access under the CC-BY-NC 4.0 License which allows users to copy, redistribute and make derivative works for non-commercial purposes, provided the original work is cited correctly.
spellingShingle 27th Annual Meeting of the ISCP
Blaha, V
Margoczy, R
Petrov, I
Postadzhiyan, A
Raslova, K
Rosolova, H
Bridges, I
Dhalwani, NN
Zachlederova, M
Ray, KK
Evolocumab is initiated in Central and Eastern Europe at Much Higher LDL-C Levels than Recommended in Guidelines: Results from the Observational HEYMANS Study
title Evolocumab is initiated in Central and Eastern Europe at Much Higher LDL-C Levels than Recommended in Guidelines: Results from the Observational HEYMANS Study
title_full Evolocumab is initiated in Central and Eastern Europe at Much Higher LDL-C Levels than Recommended in Guidelines: Results from the Observational HEYMANS Study
title_fullStr Evolocumab is initiated in Central and Eastern Europe at Much Higher LDL-C Levels than Recommended in Guidelines: Results from the Observational HEYMANS Study
title_full_unstemmed Evolocumab is initiated in Central and Eastern Europe at Much Higher LDL-C Levels than Recommended in Guidelines: Results from the Observational HEYMANS Study
title_short Evolocumab is initiated in Central and Eastern Europe at Much Higher LDL-C Levels than Recommended in Guidelines: Results from the Observational HEYMANS Study
title_sort evolocumab is initiated in central and eastern europe at much higher ldl-c levels than recommended in guidelines: results from the observational heymans study
topic 27th Annual Meeting of the ISCP
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10316339/
https://www.ncbi.nlm.nih.gov/pubmed/37405342
http://dx.doi.org/10.15420/ecr.2023.18.PO19
work_keys_str_mv AT blahav evolocumabisinitiatedincentralandeasterneuropeatmuchhigherldlclevelsthanrecommendedinguidelinesresultsfromtheobservationalheymansstudy
AT margoczyr evolocumabisinitiatedincentralandeasterneuropeatmuchhigherldlclevelsthanrecommendedinguidelinesresultsfromtheobservationalheymansstudy
AT petrovi evolocumabisinitiatedincentralandeasterneuropeatmuchhigherldlclevelsthanrecommendedinguidelinesresultsfromtheobservationalheymansstudy
AT postadzhiyana evolocumabisinitiatedincentralandeasterneuropeatmuchhigherldlclevelsthanrecommendedinguidelinesresultsfromtheobservationalheymansstudy
AT raslovak evolocumabisinitiatedincentralandeasterneuropeatmuchhigherldlclevelsthanrecommendedinguidelinesresultsfromtheobservationalheymansstudy
AT rosolovah evolocumabisinitiatedincentralandeasterneuropeatmuchhigherldlclevelsthanrecommendedinguidelinesresultsfromtheobservationalheymansstudy
AT bridgesi evolocumabisinitiatedincentralandeasterneuropeatmuchhigherldlclevelsthanrecommendedinguidelinesresultsfromtheobservationalheymansstudy
AT dhalwaninn evolocumabisinitiatedincentralandeasterneuropeatmuchhigherldlclevelsthanrecommendedinguidelinesresultsfromtheobservationalheymansstudy
AT zachlederovam evolocumabisinitiatedincentralandeasterneuropeatmuchhigherldlclevelsthanrecommendedinguidelinesresultsfromtheobservationalheymansstudy
AT raykk evolocumabisinitiatedincentralandeasterneuropeatmuchhigherldlclevelsthanrecommendedinguidelinesresultsfromtheobservationalheymansstudy

Ejemplares similares